Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.

J Clin Endocrinol Metab. 2005 Mar;90(3):1502-10. Epub 2004 Nov 30.

PMID:
15572415
[PubMed - indexed for MEDLINE]
2.

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.

J Clin Endocrinol Metab. 2004 Feb;89(2):503-10.

PMID:
14764753
[PubMed - indexed for MEDLINE]
3.

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT.

JAMA. 2008 Jan 2;299(1):39-52. doi: 10.1001/jama.2007.51. Erratum in: JAMA. 2008 Feb 13;299(6):634.

PMID:
18167405
[PubMed - indexed for MEDLINE]
4.

The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.

Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ.

J Clin Endocrinol Metab. 2003 Mar;88(3):1167-73.

PMID:
12629101
[PubMed - indexed for MEDLINE]
5.

Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.

Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, Swerdloff RS.

J Clin Endocrinol Metab. 1996 Oct;81(10):3654-62.

PMID:
8855818
[PubMed - indexed for MEDLINE]
6.

Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.

Vaughan C, Goldstein FC, Tenover JL.

J Androl. 2007 Nov-Dec;28(6):875-82. Epub 2007 Jul 3.

PMID:
17609296
[PubMed - indexed for MEDLINE]
Free Article
7.

Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

Borst SE, Yarrow JF, Conover CF, Nseyo U, Meuleman JR, Lipinska JA, Braith RW, Beck DT, Martin JS, Morrow M, Roessner S, Beggs LA, McCoy SC, Cannady DF 2nd, Shuster JJ.

Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E433-42. doi: 10.1152/ajpendo.00592.2013. Epub 2013 Dec 10.

PMID:
24326421
[PubMed - indexed for MEDLINE]
8.

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N; Testosterone Gel Study Group.

J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53.

PMID:
10946892
[PubMed - indexed for MEDLINE]
9.

A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.

Sheffield-Moore M, Dillon EL, Casperson SL, Gilkison CR, Paddon-Jones D, Durham WJ, Grady JJ, Urban RJ.

J Clin Endocrinol Metab. 2011 Nov;96(11):E1831-7. doi: 10.1210/jc.2011-1262. Epub 2011 Aug 24.

PMID:
21865352
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.

PMID:
9745419
[PubMed - indexed for MEDLINE]
11.

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.

Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C.

J Clin Endocrinol Metab. 2004 Mar;89(3):1174-80.

PMID:
15001605
[PubMed - indexed for MEDLINE]
12.

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.

PMID:
8923860
[PubMed - indexed for MEDLINE]
13.

Effects of testosterone supplementation in the aging male.

Tenover JS.

J Clin Endocrinol Metab. 1992 Oct;75(4):1092-8.

PMID:
1400877
[PubMed - indexed for MEDLINE]
14.

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.

Page ST, Hirano L, Gilchriest J, Dighe M, Amory JK, Marck BT, Matsumoto AM.

J Urol. 2011 Jul;186(1):191-7. doi: 10.1016/j.juro.2011.03.026. Epub 2011 May 14.

PMID:
21575967
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.

Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS.

J Clin Endocrinol Metab. 2013 May;98(5):1891-900. doi: 10.1210/jc.2012-3695. Epub 2013 Mar 26.

PMID:
23533227
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Testosterone supplementation therapy for older men: potential benefits and risks.

Gruenewald DA, Matsumoto AM.

J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115. Review.

PMID:
12534854
[PubMed - indexed for MEDLINE]
17.

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ.

J Clin Endocrinol Metab. 2001 Sep;86(9):4078-88.

PMID:
11549629
[PubMed - indexed for MEDLINE]
18.

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS.

J Clin Endocrinol Metab. 2004 May;89(5):2085-98.

PMID:
15126525
[PubMed - indexed for MEDLINE]
19.

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.

Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM; AIDS Clinical Trials Group Protocol A5079 Study Team.

J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57. Epub 2006 Dec 12.

PMID:
17164307
[PubMed - indexed for MEDLINE]
20.

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.

Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.

Clin Endocrinol (Oxf). 1998 Oct;49(4):421-32.

PMID:
9876338
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk